Skip to main content
Market intelligence
RYTMHealthcare

Rhythm Pharmaceuticals Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 22, 2026Lynn A. TetraultCorporate insiderSale37,000$100.32$3,711,896
May 15, 2026Christopher Paul GermanCorporate Controller & CAOSale4,643$92.21$428,131